Adverse reactions to chloroquine and amodiaquine as used for malaria prophylaxis: a review of the literature.
This paper reviews the published material on adverse reactions to chloroquine (CQ) and amodiaquine (ADQ) as used for anti-malarial chemophrophylaxis. Dermatologic reactions, including pruritus and photosensitivity, appear to be rather common. Ophthalmologic reactions include difficulty in visual accommodation, corneal deposits, and retinopathy, the last a serious condition that is reversible in its early stage by drug withdrawal, and that generally will not occur with less than four years of weekly CQ use. Neuromyopathy is a rare and serious reaction that may develop idiosyncratically after a small cumulative dose; it, too, is reversible by drug withdrawal. Seizures, syndromes of involuntary movements, psychosis, and ototoxicity have been reported occasionally. Fatal toxic overdoses may occur, especially following accidental ingestion by children. ADQ should not be used for anti-malarial prophylaxis because of associated agranulocytosis. Rabies vaccine given intradermally is less effective for pre-exposure prophylaxis while the patient is taking CQ. Care should be taken when prescribing prophylactic CQ to patients with heart block. In spite of its adverse effects, however, CQ is generally an extremely safe drug. Cq prophylaxis is recommended for pregnant women in CQ-sensitive malarial areas.
R
R
Wittes
Arch Ophthalmol. 1963 Oct;70:474-81
14078869
Am J Med. 1983 Jul 18;75(1A):11-8
6408923
Lancet. 1984 Aug 18;2(8399):402-3
6147478
Clin Toxicol. 1978;13(3):361-9
743865
J Toxicol Clin Toxicol. 1983 May;20(3):271-9
6620441
CMAJ. 1987 Oct 1;137(7):635-6
3651930
Can Med Assoc J. 1985 Feb 1;132(3):265-7
3881157
J Clin Invest. 1948 May;27(3 Pt 2):60-5
16695637
Trop Doct. 1981 Jul;11(3):97-101
7268916
JAMA. 1963 Sep 28;185:1044
14045578
S Afr Med J. 1982 Nov 6;62(20):735-7
7135135
J Laryngol Otol. 1978 Aug;92(8):701-3
681846
Am J Med. 1983 Jul 18;75(1A):5-10
6603166
Am J Med. 1983 Jul 18;75(1A):40-5
6869410
Ann Phys Med. 1968 Feb;9(5):189-92
4298052
Br Med J. 1976 Jul 24;2(6029):214-5
974497
Trans Am Ophthalmol Soc. 1962;60:517-52
13985756
Br Med J. 1973 Dec 22;4(5894):736
4776885
Cleve Clin Q. 1958 Apr;25(2):95-111
13523829
Am J Med. 1983 Jul 18;75(1A):35-9
6869409
J Gynecol Obstet Biol Reprod (Paris). 1982;11(8):981-90
6763616
Can Med Assoc J. 1963 Nov 2;89:917-20
14052974
Br Med J (Clin Res Ed). 1982 Dec 11;285(6356):1703-4
6216940
Arch Pathol. 1972 Mar;93(3):209-18
5009996
Br Med J. 1978 Apr 29;1(6120):1109-10
638620
Arch Dermatol. 1982 May;118(5):290
7082015
Proc Staff Meet Mayo Clin. 1963 Nov 6;38:501-13
14090994
N Engl J Med. 1986 Sep 11;315(11):712-3
3748079
Postgrad Med J. 1979 Sep;55(646):569
514939
Br Med J. 1977 Aug 20;2(6085):520
890388
Lancet. 1986 Feb 22;1(8478):411-4
2868340
Arch Ophthalmol. 1982 Aug;100(8):1300-4
7103815
Q J Med. 1971 Jan;40(157):85-93
4253656
Br Med J. 1977 May 21;1(6072):1350
861620
J Neuropathol Exp Neurol. 1980 Jan;39(1):65-81
7359173
J Clin Psychopharmacol. 1982 Feb;2(1):40-7
7040501
Trop Geogr Med. 1978 Sep;30(3):331-5
734759
Br Med J. 1977 Apr 9;1(6066):945-6
851793
Arch Otolaryngol. 1964 Oct;80:407-12
14198705
Am J Med. 1983 Jul 18;75(1A):1-4
6346869
Br Med J. 1967 Apr 22;2(5546):219-20
5297866
J Laryngol Otol. 1979 Aug;93(8):809-15
490032
Can Med Assoc J. 1985 Apr 1;132(7):737
3978494
Am J Med. 1983 Jul 18;75(1A):25-34
6869408
N Engl J Med. 1986 Jan 30;314(5):280-4
3510393
Obstet Gynecol. 1973 Nov;42(5):696-700
4584194
Am Heart J. 1970 Jun;79(6):831-42
5419357
J Am Acad Dermatol. 1981 Jun;4(6):650-5
6165744
JAMA. 1964 Feb 1;187:373-5
14085046
Arch Dermatol. 1963 Oct;88:419-26
14051353
Arch Dermatol. 1984 Jan;120(1):80-2
6691718
J Pharmacol Exp Ther. 1967 Nov;158(2):323-31
6065153
Arch Dermatol. 1963 Sep;88:280-9
14043620
Trans R Soc Trop Med Hyg. 1969;63(4):549
5821283
East Afr Med J. 1980 Jul;57(7):505-7
7398569